Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: Global

Triglav Zdravje in Farmacija

+ Add to Watchlist

TRIZDFA:SV

23.75 EUR 0.08 0.34%

As of 07:46:00 ET on 05/22/2015.

Snapshot for Triglav Zdravje in Farmacija (TRIZDFA)

Year To Date: +20.93% 3-Month: +7.03% 3-Year: +28.90% 52-Week Range: 16.17 - 24.67
1-Month: -2.74% 1-Year: +47.52% 5-Year: - Beta vs SBITOP: 0.41

Mutual Fund Chart for TRIZDFA

No chart data available.
  • TRIZDFA:SV 23.75
  • 1M
  • 1Y
Interactive TRIZDFA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for TRIZDFA

Triglav Zdravje in farmacija is a UCITS certified open-end fund incorporated in Slovenia. The Fund's objective is to achieve long-term capital growth. The Fund primarily invests in equitiy securities from global healthcare sector.

Inception Date: 10-03-2011 Telephone: Tel.: +386 1 300-73-00
Managers: GASPER DOVC
Web Site: www.triglavskladi.si

Fundamentals for TRIZDFA

NAV (on 2015-05-22) 23.75
Assets (M) (on 2015-05-22) 23.38
Fund Leveraged N
Minimum Investment -
Minimum Subsequent Investment -

Dividends for TRIZDFA

No dividends reported

Fees & Expenses for TRIZDFA

Front Load 4.00
Back Load 0.00
Current Mgmt Fee 2.50
Redemption Fee 0.00
12b1 Fee -
Expense Ratio 2.76

Top Fund Holdings for TRIZDFA

Filing Date: 04/30/2015
Name Position Value % of Total
Johnson & Johnson 12,680 1,121,676 4.940%
Novartis AG 11,469 1,053,558 4.640%
iShares Global Healthcare ETF 10,001 960,464 4.230%
Gilead Sciences Inc 10,209 915,052 4.030%
Pfizer Inc 27,315 819,687 3.610%
Roche Holding AG 3,077 787,898 3.470%
Actavis plc 3,007 758,380 3.340%
Novo Nordisk A/S 13,473 683,451 3.010%
Sanofi 7,555 667,556 2.940%
Merck & Co Inc 11,970 635,768 2.800%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil